Mortality results from the Göteborg randomised population-based prostate-cancer screening trial - Wikidata - wikimedia - TriplyDB

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

http://www.wikidata.org/entity/Q33873969

about

Screening for prostate cancer Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.Clinical validity and utility of genetic risk scores in prostate cancer Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion.Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic Review Current status of active surveillance in prostate cancer Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians Emerging PSA-based tests to improve screening Population screening for prostate cancer: an overview of available studies and meta-analysis Overdiagnosis and overtreatment of prostate cancer Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles Management of low (favourable)-risk prostate cancer Quality of life issues in men undergoing androgen deprivation therapy: a review Computer aided-diagnosis of prostate cancer on multiparametric MRI: a technical review of current research Prostate cancer: ESMO Consensus Conference Guidelines 2012 The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening.Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.Prostate cancer screening in Brazil: should it be done or not?Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics Randomised prostate cancer screening trial: 20 year follow-up The role of MRI in prostate cancer diagnosis and management.Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening.[Rates of prostate-specific antigen testing for early detection of prostate cancer: a first comparison of German results with current international data].Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer.The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial.Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.Protease Expression Levels in Prostate Cancer Tissue Can Explain Prostate Cancer-Associated Seminal Biomarkers-An Explorative Concept Study.Predictive value of digital rectal examination for prostate cancer detection is modified by obesity Laser ablation as focal therapy for prostate cancer.Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort Risk of suicide in men with low-risk prostate cancer.Screening for prostate cancer: the debate continues Cost consideration in utilization of multiparametric magnetic resonance imaging in prostate cancer.

P2860

Q24201690-F2575AB6-715A-48B3-A2CE-7D474AA8CF91 Q24608493-BB6DD500-9D02-4766-8679-B6917576815C Q24620320-011692CD-8B7D-4937-BDC2-099352D74AB0 Q26746219-16BBD372-E42C-4690-9072-5E59B1BC61B9 Q26746913-EB8EF140-6B17-4DAE-9CAC-8C1C5A75B3B8 Q26748873-08D3141C-35F0-417A-AE07-DE8669080259 Q26766307-8534FE6B-7A18-462D-9879-130D1811D2A1 Q26781093-879714F0-D4F6-4F9C-9F96-2A24CE88DD90 Q26824913-75D1ADB0-46A2-424F-90E3-9267D978BB22 Q26827438-8413DA74-5A9E-4D8D-B1C8-AE7D42DBB62E Q26828563-48F17A35-DCE0-4011-8F58-DBAF8D767E98 Q26829319-5247B5D5-22BF-4107-91CF-7A97CBE5137D Q26859596-FF46F2CD-72EE-4AA2-ACDA-0592D5BB308B Q26865810-AA99FAAB-78C5-4BC0-8378-05D826AA12B9 Q26996501-2B40794F-EDFE-46AF-AA19-179AB064124B Q27002887-B1EED1E1-A9F6-4528-A3A8-E4E468096C58 Q27004458-1C2FBA0F-34CD-4A0B-A006-1BFC7A49F1F6 Q27022847-70813BF9-D508-4EE5-A3A8-47F564C88DC8 Q27314872-3E4FB7A0-C893-4660-8875-9D469636AF1F Q27852185-35B77CB5-7654-443D-92A8-024B797C8460 Q28068688-E8F83781-617F-450F-B5E1-BC8B6DAE585E Q28251617-477D3070-EDA5-4AFA-9A48-604D166FBD96 Q28482384-01712AFA-CFAF-4D71-9932-7787A7A2AC73 Q28741447-19FAF2D7-60E6-4E35-B1A1-312D68535E6F Q30245245-30019BAF-FB3F-4620-9415-9281D333CD29 Q30402074-679E5819-08F7-4BF5-BDB3-5D6EE4770DCE Q30793372-5E6E6274-6D0D-4795-80EB-186C148D07E8 Q30878080-EBB8CDFC-C4D0-4E16-9B3B-C1ABB82823B8 Q33585860-7D510282-A31A-4BD4-A7DD-ADA7DF598C7A Q33594364-A581747D-1E64-4879-AF68-D2E65CA0886B Q33622330-316565BF-E678-4474-B984-446E9DF63DD8 Q33669598-57ECC48A-7DFB-4F16-9ED7-E6F25E615E9F Q33677904-DA96119C-7D55-4DD0-B2D2-562E826D27A0 Q33754996-A07FEEE0-CA43-4101-BD43-56BE7227689B Q33778985-C4F9FC5C-E960-4CF6-86E4-2483C24CE865 Q33807516-914062B0-C243-412F-9906-029FD7C38A15 Q33820579-AB4AEBA2-1C8D-4332-A83D-09D0A2CD2FDA Q33848638-F1FC6E94-626B-4D6C-A3B5-BC6FC7184011 Q33885776-4CA73F52-B3C3-4007-86F3-E1329ABB0A86 Q33890201-026E8195-6374-4AC9-9C81-49E1463EE5C7

P2860

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

http://www.wikidata.org/entity/Q33873969

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Mortality results from the Göt ...... rostate-cancer screening trial

@ast

Mortality results from the Göt ...... rostate-cancer screening trial

@en

type

label

Mortality results from the Göt ...... rostate-cancer screening trial

@ast

Mortality results from the Göt ...... rostate-cancer screening trial

@en

prefLabel

Mortality results from the Göt ...... rostate-cancer screening trial

@ast

Mortality results from the Göt ...... rostate-cancer screening trial

@en

P1433

Q33873969-B75788BF-EC97-4C83-B2DA-3B5ECE6302C3

P1476

Q33873969-2428B4BE-F7E8-4937-A8AF-2104478814B4

P2093

Q33873969-07C0563B-E479-4569-A702-383FBB62FCC9

Q33873969-0FCC3DF8-31B1-4695-AEA7-82E1D72AC981

Q33873969-3F51ECA6-698F-4028-BB0A-4204829C985B

Q33873969-AD8D256A-DBCB-45EF-978C-DB7F0985699C

Q33873969-BB3D4EDD-A16A-452E-AE1B-1DF7042CED07

Q33873969-E12E9CC4-4758-47AD-B5B8-93F0647B8CF6

Q33873969-FE58FDFB-FFFD-499B-803B-7BFE945461A8

P2860

Q33873969-01A037F5-FF2A-437E-BE2D-871C16586F5E

Q33873969-03260504-0B7C-46A6-BB58-23EDC81B9FE7

Q33873969-0869BDC7-DAF2-4128-8DDE-A9F64ED1294B

Q33873969-09081008-B3A7-4513-8A96-DFE3626202EA

Q33873969-0CE1C67F-7DF5-4A53-ADC3-E43218C81199

Q33873969-165CC3A8-862E-4785-B015-00E693A4187C

Q33873969-170DF6BB-0D3E-4F35-869B-5AE7D4423BFC

Q33873969-1E0C3A39-B65A-4777-82F0-737FB38B71C9

Q33873969-1E38E202-C05F-4617-81DD-B22E665A6096

Q33873969-215949A8-4374-4148-9BB7-69BD53A904CC

P304

Q33873969-B7AC17B0-C508-47FF-B449-B46AB599DB52

P31

Q33873969-64A3B438-F865-403D-A458-3A2A244C4EEF

P356

Q33873969-5140AD05-E186-4FC7-A410-E941C8FB36A8

P433

Q33873969-057180E8-FEAE-47B0-8D48-5691465230E8

P478

Q33873969-B06E1F93-E88A-4F96-BB1E-1617F749FBFD

P50

Q33873969-50DAD62C-55CF-43B9-BCFA-E7A9B68A4127

Q33873969-5223AA60-7EDD-42C9-9B93-4E0F42A403AF

Q33873969-75ADF0F0-531E-4673-91F4-5149800CD4B7

P577

Q33873969-9F44C5BD-AC75-47A6-BDFC-691576C0F972

P698

Q33873969-FFA7B5E7-1D9D-4AC6-8A6C-F75E56EE6FB1

P932

Q33873969-4B77B39B-76F4-4DA0-A51F-82DAF955FFB1

P356

S1470-2045(10)70146-7

P1433

The Lancet Oncology

P1476

Mortality results from the Göt ...... rostate-cancer screening trial

@en

P2093

Ali Khatami

http://www.w3.org/2001/XMLSchema#string

Carl-Gustaf Pihl

http://www.w3.org/2001/XMLSchema#string

Gunnar Aus

http://www.w3.org/2001/XMLSchema#string

Jonas Hugosson

http://www.w3.org/2001/XMLSchema#string

Pär Lodding

http://www.w3.org/2001/XMLSchema#string

Sigrid Carlsson

http://www.w3.org/2001/XMLSchema#string

Svante Bergdahl

http://www.w3.org/2001/XMLSchema#string

P2860

Screening for breast cancer with mammography

Mortality results from a randomized prostate-cancer screening trial

Screening for breast cancer: an update for the U.S. Preventive Services Task Force

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

Screening and prostate-cancer mortality in a randomized European study

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

Long-term effects of mammography screening: updated overview of the Swedish randomised trials.

Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial.

P304

725-732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1470-2045(10)70146-7

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20598634

http://www.w3.org/2001/XMLSchema#string

P932

4089887

http://www.w3.org/2001/XMLSchema#string